Kris V Kowdley

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 21

Top Topics

Top Venues

Hepatology communications

Hepatology (Baltimore, Md.)

Postgraduate medicine

Expert opinion on investigational drugs

This page only lists publications with an associated author ORCID identifier.

Publications

Alina M Allen, Michael R Charlton, Kenneth Cusi, Stephen A Harrison, Kris V Kowdley, Mazen Noureddin, Jay H Shubrook
Guideline-based management of metabolic dysfunction-associated steatotic liver disease in the primary care setting. Postgraduate medicine (2024)
Aalam Sohal, Kris V Kowdley
Novel preclinical developments of the primary sclerosing cholangitis treatment landscape. Expert opinion on investigational drugs 33 (4) (2024)
Alina M Allen, Michael R Charlton, Kenneth Cusi, Stephen A Harrison, Kris V Kowdley, Mazen Noureddin, Jay H Shubrook
Guideline-based management of metabolic dysfunction-associated steatotic liver disease in the primary care setting. Postgraduate medicine 136 (3) (2024)
Alina M Allen, Michael R Charlton, Kenneth Cusi, Stephen A Harrison, Kris V Kowdley, Mazen Noureddin, Jay H Shubrook
Guideline-based management of metabolic dysfunction-associated steatotic liver disease in the primary care setting. Postgraduate medicine 136 (3) (2024)
Aalam Sohal, Kris V Kowdley
Novel preclinical developments of the primary sclerosing cholangitis treatment landscape. Expert opinion on investigational drugs 33 (4) (2024)
Alina M Allen, Michael R Charlton, Kenneth Cusi, Stephen A Harrison, Kris V Kowdley, Mazen Noureddin, Jay H Shubrook
Guideline-based management of metabolic dysfunction-associated steatotic liver disease in the primary care setting. Postgraduate medicine (2024)
Naga P Chalasani, Eduardo Vilar-Gomez, Stephen Caldwell, Katherine P Yates, Anna Mae Diehl, Brent A Neuschwander-Tetri, Srinivasan Dasarathy, Kris V Kowdley, Norah A Terrault, Laura A Wilson, James Tonascia, Arun J Sanyal
PNPLA3 rs738409, age, diabetes, sex, and advanced fibrosis jointly contribute to the risk of major adverse liver outcomes in metabolic dysfunction-associated steatotic liver disease. Hepatology (Baltimore, Md.) (2024)
Aalam Sohal, Kris V Kowdley
Novel preclinical developments of the primary sclerosing cholangitis treatment landscape. Expert opinion on investigational drugs (2024)
Aalam Sohal, Kris V Kowdley
Novel preclinical developments of the primary sclerosing cholangitis treatment landscape. Expert opinion on investigational drugs (2024)
Arun J Sanyal, Stephen Caldwell, Quentin Mark Anstee, Vlad Ratziu, Kris V Kowdley, Mary E Rinella, Stephen A Harrison, Murray B Resnick, Thomas Capozza, Sangeeta Sawhney, Nirav Shelat, Zobair M Younossi
Utility of pathologist panels for achieving consensus in NASH histologic scoring in clinical trials: Data from a phase 3 study. Hepatology communications 8 (1) (2023)
Arun J Sanyal, Stephen Caldwell, Quentin Mark Anstee, Vlad Ratziu, Kris V Kowdley, Mary E Rinella, Stephen A Harrison, Murray B Resnick, Thomas Capozza, Sangeeta Sawhney, Nirav Shelat, Zobair M Younossi
Utility of pathologist panels for achieving consensus in NASH histologic scoring in clinical trials: Data from a phase 3 study. Hepatology communications 8 (1) (2023)
Arun J Sanyal, Stephen Caldwell, Quentin Mark Anstee, Vlad Ratziu, Kris V Kowdley, Mary E Rinella, Stephen A Harrison, Murray B Resnick, Thomas Capozza, Sangeeta Sawhney, Nirav Shelat, Zobair M Younossi
Utility of pathologist panels for achieving consensus in NASH histologic scoring in clinical trials: Data from a phase 3 study. Hepatology communications 8 (1) (2023)
Gideon M Hirschfield, Mitchell L Shiffman, Gideon M Hirschfield, Kris V Kowdley, John M Vierling, Cynthia Levy, Andreas E Kremer, Ehud Zigmond, Pietro Andreone, Stuart C Gordon, Christopher L Bowlus, Eric J Lawitz, Richard J Aspinall, Daniel S Pratt, Karina Raikhelson, Maria S Gonzalez-Huezo, Michael A Heneghan, Sook-Hyang Jeong, Alma L Ladrón de Guevara, Marlyn J Mayo, Georgios N Dalekos, Joost Paulus Hubertus Drenth, Ewa Janczewska, Barbara A Leggett, Frederik Nevens, Víctor Vargas, Eli Zuckerman, Christophe Corpechot, Eduardo Fassio, Holger Hinrichsen, Invernizzi Pietro, Palak J Trivedi, Lisa Forman, David E J Jones, Stephen D Ryder, Mark G Swain, Alexandra Steinberg, Pol F Boudes, Yun-Jung Choi, Charles A McWherter, null null
Seladelpar efficacy and safety at 3 months in patients with primary biliary cholangitis: ENHANCE, a phase 3, randomized, placebo-controlled study. Hepatology (Baltimore, Md.) (2023)
Jun Xu, Ya Wang, Mina Khoshdeli, Matt Peach, Jen-Chieh Chuang, Julie Lin, Wen-Wei Tsai, Sangeetha Mahadevan, Wesley Minto, Lauri Diehl, Ruchi Gupta, Michael Trauner, Keyur Patel, Mazen Noureddin, Kris V Kowdley, Aliya Gulamhusein, Christopher L Bowlus, Ryan S Huss, Robert P Myers, Chuhan Chung, Andrew N Billin
IL-31 levels correlate with pruritus in patients with cholestatic and metabolic liver diseases and is farnesoid X receptor responsive in NASH. Hepatology (Baltimore, Md.) (2022)
Christine C Hsu, Nizar H Senussi, Kleber Y Fertrin, Kris V Kowdley
Iron overload disorders. Hepatology communications 6 (8) (2022)
Peter Lymberopoulos, Sameer Prakash, Anjiya Shaikh, Anshul Bhatnagar, Anthony K Allam, Karthik Goli, John A Goss, Fasiha Kanwal, Abbas Rana, Kris V Kowdley, Prasun Jalal, null George Cholankeril
Long-term outcomes and trends in liver transplantation for hereditary hemochromatosis in the United States. Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society (2022)
Samer Gawrieh, Laura A Wilson, Katherine P Yates, Oscar W Cummings, Eduardo Vilar-Gomez, Veeral H Ajmera, Kris V Kowdley, William M Rosenberg, James Tonascia, Naga P Chalasani
Relationship of ELF and PIIINP With Liver Histology and Response to Vitamin E or Pioglitazone in the PIVENS Trial. Hepatology communications 5 (5) (2021)
Kris V Kowdley, Eric M Gochanour, Vinay Sundaram, Raj A Shah, Priya Handa
Hepcidin Signaling in Health and Disease: Ironing Out the Details. Hepatology communications 5 (5) (2021)
Amreen M Dinani, Kris V Kowdley, Mazen Noureddin
Application of Artificial Intelligence for Diagnosis and Risk Stratification in NAFLD and NASH: The State of the Art. Hepatology (Baltimore, Md.) 74 (4) (2021)
Samer Gawrieh, Mazen Noureddin, Nicole Loo, Rizwana Mohseni, Vivek Awasty, Kenneth Cusi, Kris V Kowdley, Michelle Lai, Eugene Schiff, Deven Parmar, Pankaj Patel, Naga P Chalasani
Saroglitazar, a PPAR-α/γ Agonist, for Treatment of NAFLD: A Randomized Controlled Double-Blind Phase 2 Trial. Hepatology (Baltimore, Md.) 74 (4) (2021)
Zobair M Younossi, Maria Stepanova, Mazen Noureddin, Kris V Kowdley, Simone I Strasser, Anita Kohli, Peter Ruane, Mitchell L Shiffman, Aasim Sheikh, Nadege Gunn, Stephen H Caldwell, Ryan S Huss, Robert P Myers, Vincent Wai-Sun Wong, Naim Alkhouri, Zachary Goodman, Rohit Loomba
Improvements of Fibrosis and Disease Activity Are Associated With Improvement of Patient-Reported Outcomes in Patients With Advanced Fibrosis Due to Nonalcoholic Steatohepatitis. Hepatology communications 5 (7) (2021)